• 1. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 2. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboximidic acids and derivatives Imidoesters Imidolactones

Recent Advances in the Study of 2-Ethoxy-1-pyrroline (CAS: 931-46-4) and Its Applications in Chemical Biology and Pharmaceutical Research

2-Ethoxy-1-pyrroline (CAS: 931-46-4) is a heterocyclic compound that has recently garnered significant attention in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential applications in drug development. The compound's pyrroline core, combined with the ethoxy substituent, makes it a versatile intermediate for the synthesis of more complex molecules with potential pharmacological activities.

Recent studies have highlighted the role of 2-Ethoxy-1-pyrroline as a key intermediate in the synthesis of bioactive molecules. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the synthesis of novel pyrrolidine-based inhibitors targeting bacterial enzymes. The study reported that derivatives of 2-Ethoxy-1-pyrroline exhibited potent inhibitory activity against bacterial efflux pumps, suggesting potential applications in addressing antibiotic resistance. The researchers employed a combination of computational modeling and in vitro assays to validate the compound's mechanism of action, providing a robust foundation for further drug development efforts.

Another significant area of research involves the compound's potential as a precursor for the synthesis of neuroactive agents. A 2022 study in Bioorganic & Medicinal Chemistry Letters explored the use of 2-Ethoxy-1-pyrroline in the development of GABA receptor modulators. The study found that structural modifications of the pyrroline ring could enhance binding affinity to specific GABA receptor subtypes, offering a promising avenue for the treatment of neurological disorders such as epilepsy and anxiety. These findings underscore the compound's versatility and its potential to serve as a scaffold for the design of new central nervous system (CNS) therapeutics.

In addition to its pharmacological applications, 2-Ethoxy-1-pyrroline has also been investigated for its role in chemical biology. A recent preprint on ChemRxiv detailed its use as a reactive handle for bioconjugation, enabling the site-specific modification of proteins and peptides. This approach leverages the compound's electrophilic properties to facilitate covalent bonding with nucleophilic residues, such as cysteine, in biomolecules. Such applications are particularly relevant for the development of targeted drug delivery systems and diagnostic tools, highlighting the compound's broad utility beyond traditional drug discovery.

Despite these promising developments, challenges remain in optimizing the synthesis and stability of 2-Ethoxy-1-pyrroline derivatives. A 2023 review in Organic Process Research & Development highlighted the need for more efficient and scalable synthetic routes to meet the growing demand for this compound in industrial and academic settings. Advances in catalytic methods, such as asymmetric hydrogenation, have shown potential in addressing these challenges, but further research is needed to refine these processes for large-scale production.

In conclusion, 2-Ethoxy-1-pyrroline (CAS: 931-46-4) represents a valuable building block in chemical biology and pharmaceutical research, with demonstrated applications in antibiotic development, CNS therapeutics, and bioconjugation. Ongoing research continues to uncover new opportunities for this compound, driven by its structural versatility and biological activity. Future studies should focus on overcoming synthetic challenges and expanding its therapeutic potential, paving the way for innovative treatments in various medical fields.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)